{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:50:46Z","timestamp":1791355846250,"version":"4.3.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,7,24]],"date-time":"2009-07-24T00:00:00Z","timestamp":1248393600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1007\/s12185-009-0380-8","type":"journal-article","created":{"date-parts":[[2009,7,23]],"date-time":"2009-07-23T06:34:12Z","timestamp":1248330852000},"page":"205-211","source":"Crossref","is-referenced-by-count":20,"title":["Serum thymidine kinase 1 concentration in Chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors"],"prefix":"10.1007","volume":"90","author":[{"given":"Wei","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kou-Rong","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,7,24]]},"reference":[{"key":"380_CR1","first-page":"117","volume":"70","author":"Q He","year":"1996","unstructured":"He Q, Skog S, Wang N, Eriksson S, Tribukait B. Characterization of a peptide antibody against a C-terminal part of human and mouse cytosolic thymidine kinase, which is a marker for cell proliferation. Eur J Cell Biol. 1996;70:117\u201324.","journal-title":"Eur J Cell Biol."},{"key":"380_CR2","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1128\/MCB.24.2.514-526.2004","volume":"24","author":"PY Ke","year":"2004","unstructured":"Ke PY, Chang ZF. Mitotic degradation of human thymidine kinase 1 is dependent on the anaphase-promoting complex\/cyclosome-CDH1-mediated pathway. Mol Cell Biol. 2004;24:514\u201326.","journal-title":"Mol Cell Biol."},{"key":"380_CR3","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1002\/1097-0142(19841201)54:11<2450::AID-CNCR2820541123>3.0.CO;2-R","volume":"54","author":"CF Kallander","year":"1984","unstructured":"Kallander CF, Simonsson B, Hagberg H, Gronowitz JS. Serum deoxythymidine kinase gives prognostic information in chronic lymphocytic leukemia. Cancer. 1984;54:2450\u20135.","journal-title":"Cancer."},{"key":"380_CR4","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1128\/MCB.11.5.2538","volume":"11","author":"MG Kauffman","year":"1991","unstructured":"Kauffman MG, Kelly TJ. Cell cycle regulation of thymidine kinase: residues near the carboxyl terminus are essential for the specific degradation of the enzyme at mitosis. Mol Cell Biol. 1991;11:2538\u201346.","journal-title":"Mol Cell Biol."},{"key":"380_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF01715117","volume":"65","author":"M Hallek","year":"1992","unstructured":"Hallek M, Wanders L, Strohmeyer S, Emmerich B. Thymidine kinase: a tumor marker with prognostic value for non-Hodgkin\u2019s lymphoma and a broad range of potential clinical applications. Ann Hematol. 1992;65:1\u20135.","journal-title":"Ann Hematol."},{"key":"380_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3109\/10428199509064927","volume":"18","author":"S Suki","year":"1995","unstructured":"Suki S, Swan F Jr, Tucker S, Fritsche HA, Redman JR, Rodriguez MA, et al. Risk classification for large cell lymphoma using lactate dehydrogenase, beta-2 microglobulin, and thymidine kinase. Leuk Lymphoma. 1995;18:87\u201392.","journal-title":"Leuk Lymphoma."},{"key":"380_CR7","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1002\/1097-0142(19920315)69:6<1368::AID-CNCR2820690611>3.0.CO;2-R","volume":"69","author":"R Luoni","year":"1992","unstructured":"Luoni R, Ucci G, Riccardi A, Gobbi P, Avato FM, Vignale C, et al. Serum thymidine kinase in monoclonal gammopathies. A prospective study. The Cooperative Group for Study and Treatment of Multiple Myeloma. Cancer. 1992;69:1368\u201372.","journal-title":"Cancer."},{"key":"380_CR8","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1600-0609.1987.tb00007.x","volume":"38","author":"CF Kallander","year":"1987","unstructured":"Kallander CF, Simonsson B, Gronowitz JS, Nilsson K. Serum deoxythymidine kinase correlates with peripheral lymphocyte thymidine uptake in chronic lymphocytic leukemia. Eur J Haematol. 1987;38:331\u20137.","journal-title":"Eur J Haematol."},{"key":"380_CR9","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3109\/10428199609054782","volume":"22","author":"M Hallek","year":"1996","unstructured":"Hallek M, Wanders L, Ostwald M, Busch R, Senekowitsch R, Stern S, et al. Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma. Leuk Lymphoma. 1996;22:439\u201347.","journal-title":"Leuk Lymphoma."},{"key":"380_CR10","first-page":"1732","volume":"93","author":"M Hallek","year":"1999","unstructured":"Hallek M, Langenmayer I, Nerl C, Knauf W, Dietzfelbinger H, Adorf D, et al. Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia. Blood. 1999;93:1732\u20137.","journal-title":"Blood."},{"key":"380_CR11","first-page":"4753","volume":"26","author":"Q He","year":"2006","unstructured":"He Q, Fornander T, Johansson H, Johansson U, Hu GZ, Rutqvist LE, et al. Thymidine kinase 1 in serum predicts increased risk of distant or loco-regional recurrence following surgery in patients with early breast cancer. Anticancer Res. 2006;26:4753\u20139.","journal-title":"Anticancer Res."},{"key":"380_CR12","first-page":"1013","volume":"14","author":"Q He","year":"2005","unstructured":"He Q, Zhang P, Zou L, Li H, Wang X, Zhou S, et al. Concentration of thymidine kinase 1 in serum (S-TK1) is a more sensitive proliferation marker in human solid tumors than its activity. Oncol Rep. 2005;14:1013\u20139.","journal-title":"Oncol Rep."},{"key":"380_CR13","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1182\/blood.V87.12.4990.bloodjournal87124990","volume":"87","author":"BD Cheson","year":"1996","unstructured":"Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O\u2019Brien S, et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood. 1996;87:4990\u20137.","journal-title":"Blood."},{"key":"380_CR14","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V","volume":"48","author":"JL Binet","year":"1981","unstructured":"Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer. 1981;48:198\u2013206.","journal-title":"Cancer."},{"key":"380_CR15","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.leukres.2008.02.005","volume":"32","author":"L Chen","year":"2008","unstructured":"Chen L, Zhang Y, Zheng W, Wu Y, Qiao C, Fan L, et al. Distinctive IgVH gene segments usage and mutation status in Chinese patients with chronic lymphocytic leukemia. Leuk Res. 2008;32:1491\u20138.","journal-title":"Leuk Res."},{"key":"380_CR16","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.leukres.2008.06.026","volume":"33","author":"W Xu","year":"2009","unstructured":"Xu W, Li JY, Wu YJ, Yu H, Shen QD, Tian T, et al. CD38 as a prognostic factor in Chinese patients with chronic lymphocytic leukaemia. Leuk Res. 2009;33:237\u201343.","journal-title":"Leuk Res."},{"key":"380_CR17","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1080\/10428190802308710","volume":"49","author":"HX Qiu","year":"2008","unstructured":"Qiu HX, Xu W, Cao XS, Zhou M, Shen YF, Xu YL, et al. Cytogenetic characterisation in Chinese patients with chronic lymphocytic leukemia: a prospective, multicenter study on 143 cases analysed with interphase fluorescence in situ hybridisation. Leuk Lymphoma. 2008;49:1887\u201392.","journal-title":"Leuk Lymphoma."},{"key":"380_CR18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","volume":"46","author":"KR Rai","year":"1975","unstructured":"Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood. 1975;46:219\u201334.","journal-title":"Blood."},{"key":"380_CR19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/sj.leu.2402780","volume":"17","author":"C Magnac","year":"2003","unstructured":"Magnac C, Porcher R, Davi F, Nataf J, Payelle-Brogard B, Tang RP, et al. Predictive value of serum thymidine kinase level for Ig-V mutational status in B-CLL. Leukemia. 2003;17:133\u20137.","journal-title":"Leukemia."}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-009-0380-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-009-0380-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-009-0380-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-009-0380-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T22:36:49Z","timestamp":1590014209000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-009-0380-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,24]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["380"],"URL":"https:\/\/doi.org\/10.1007\/s12185-009-0380-8","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,24]]}}}